|
1
|
World Health Organization (WHO): WHO
COVID-19 Dashboard. WHO, Geneva, 2020. https://covid19.who.int/. Accessed January 5,
2022.
|
|
2
|
Vakili K, Fathi M, Hajiesmaeili M, Salari
M, Saluja D, Tafakhori A, Sayehmiri F and Rezaei-Tavirani M:
Neurological symptoms, comorbidities, and complications of
COVID-19: A literature review and meta-analysis of observational
studies. Eur Neurol. 84:307–324. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hasan I, Saif-Ur-Rahman KM, Hayat S, Papri
N, Jahan I, Azam R, Ara G and Islam Z: Guillain-Barré syndrome
associated with SARS-CoV-2 infection: A systematic review and
individual participant data meta-analysis. J Peripher Nerv Syst.
25:335–343. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Abu-Rumeileh S, Abdelhak A, Foschi M,
Tumani H and Otto M: Guillain-Barré syndrome spectrum associated
with COVID-19: An up-to-date systematic review of 73 cases. J
Neurol. 268:1133–1170. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Uncini A, Vallat JM and Jacobs BC:
Guillain-Barré syndrome in SARS-CoV-2 infection: An instant
systematic review of the first six months of pandemic. J Neurol
Neurosurg Psychiatry. 91:1105–1110. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Toscano G, Palmerini F, Ravaglia S, Ruiz
L, Invernizzi P, Cuzzoni G, Franciotta D, Baldanti F, Daturi R,
Postorino P, et al: Guillain-Barré syndrome associated with
SARS-CoV-2. N Engl J Med. 382:2574–2576. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Aladawi M, Elfil M, Abu-Esheh B, Abu Jazar
D, Armouti A, Bayoumi A and Piccione E: Guillain barre syndrome as
a complication of COVID-19: A systematic review. Can J Neurol Sci.
49:38–48. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Leonhard SE, Mandarakas MR, Gondim FAAA,
Bateman K, Ferreira MLB, Cornblath DR, Van Doorn PA, Dourado ME,
Hughes RAC, Islam B, et al: Diagnosis and management of
Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 15:671–683.
2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Korinthenberg R, Trollmann R,
Felderhoff-Müser U, Bernert G, Hackenberg A, Hufnagel M, Pohl M,
Hahn G, Mentzel HJ, Sommer C, et al: Diagnosis and treatment of
Guillain-Barré syndrome in childhood and adolescence: An evidence-
and consensus-based guideline. Eur J Paediatr Neurol. 25:5–16.
2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Flanagan EP, McKeon A, Lennon VA, Kearns
J, Weinshenker BG, Krecke KN, Matiello M, Keegan BM, Mokri B,
Aksamit AJ and Pittock SJ: Paraneoplastic isolated myelopathy:
Clinical course and neuroimaging clues. Neurology. 76:2089–2095.
2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
McMillan HJ, Kang PB, Jones HR and Darras
BT: Childhood chronic inflammatory demyelinating
polyradiculoneuropathy: Combined analysis of a large cohort and
eleven published series. Neuromuscul Disord. 23:103–111.
2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Manji HK, George U, Mkopi NP and Manji KP:
Guillain-Barré syndrome associated with COVID-19 infection. Pan Afr
Med J. 35 (Suppl 2)(S118)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Curtis M, Bhumbra S, Felker MV, Jordan BL,
Kim J, Weber M and Friedman ML: Guillain-Barré syndrome in a child
with COVID-19 infection. Pediatrics.
147(e2020015115)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Khalifa M, Zakaria F, Ragab Y, Saad A,
Bamaga A, Emad Y and Rasker JJ: Guillain-Barré syndrome associated
with severe acute respiratory syndrome coronavirus 2 detection and
coronavirus disease 2019 in a child. J Pediatric Infect Dis Soc.
9:510–513. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Mehra B, Aggarwal V, Kumar P, Kundal M,
Gupta D, Kumar A and Dugaya SK: COVID-19-associated severe
multisystem inflammatory syndrome in children with encephalopathy
and neuropathy in an adolescent girl with the successful outcome:
An unusual presentation. Indian J Crit Care Med. 24:1276–1278.
2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Khera D, Didel S, Panda S, Tiwari S and
Singh K: Concurrent longitudinally extensive transverse myelitis
and Guillain-Barré syndrome in a child secondary to COVID-19
infection: A severe neuroimmunologic complication of COVID-19.
Pediatr Infect Dis J. 40:e236–e239. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
El Mezzeoui S, Aftiss FZ, Aabdi M, Bkiyar
H and Housni B: Guillan barre syndrome in post Covid-19 infection
in children. Ann Med Surg (Lond). 67(102524)2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Araújo NM, Ferreira LC, Dantas DP, Silva
DS, Dos Santos CA, Cipolotti R and Martins-Filho PR: First report
of SARS-CoV-2 detection in cerebrospinal fluid in a child with
Guillain-Barré syndrome. Pediatr Infect Dis J. 40:e274–e276.
2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Das KY, Midhun Raj KT, Samprathi M,
Sridhar M, Adiga R and Vemgal P: Guillain-Barré syndrome associated
with SARS-CoV-2 infection. Indian J Pediatr. 88(479)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Frank CHM, Almeida TVR, Marques EA, de
Sousa Monteiro Q, Silveira Feitoza PVS, Borba MGS, Vasconcelos HL,
de Souza Bastos M and Lacerda MVG: Guillain-Barré syndrome
associated with SARS-CoV-2 infection in a pediatric patient. J Trop
Pediatr. 67(fmaa044)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Paybast S, Gorji R and Mavandadi S:
Guillain-Barré syndrome as a neurological complication of novel
COVID-19 infection: A case report and review of the literature.
Neurologist. 25:101–103. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Al Haboob AA: Miller Fischer and posterior
reversible encephalopathy syndromes post COVID-19 infection.
Neurosciences (Riyadh). 26:295–299. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Akçay N, Menentoğlu ME, Bektaş G and
Şevketoğlu E: Axonal Guillain-Barre syndrome associated with
SARS-CoV-2 infection in a child. J Med Virol. 93:5599–5602.
2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
LaRovere KL, Riggs BJ, Poussaint TY, Young
CC, Newhams MM, Maamari M, Walker TC, Singh AR, Dapul H, Hobbs CV,
et al: Neurologic involvement in children and adolescents
hospitalized in the United States for COVID-19 or multisystem
inflammatory syndrome. JAMA Neurol. 78:536–547. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sánchez-Morales AE, Urrutia-Osorio M,
Camacho-Mendoza E, Rosales-Pedraza G, Dávila-Maldonado L,
González-Duarte A, Herrera-Mora P and Ruiz-García M: Neurological
manifestations temporally associated with SARS-CoV-2 infection in
pediatric patients in Mexico. Childs Nerv Syst. 37:2305–2312.
2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Willison HJ: The immunobiology of
Guillain-Barré syndromes. J Peripher Nerv Syst. 10:94–112.
2005.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Filosto M, Cotti Piccinelli S, Gazzina S,
Foresti C, Frigeni B, Servalli MC, Sessa M, Cosentino M, Marchioni
G, Ravaglia E, et al: Guillain-Barré syndrome and COVID-19: An
observational multicentre study from two Italian hotspot regions. J
Neurol Neurosurg Psychiatry. 92:751–756. 2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Koike H and Katsuno M: Emerging infectious
diseases, vaccines and Guillain-Barré syndrome. Clin Exp
Neuroimmunol: May 17, 2021 (Epub ahead of print).
|
|
29
|
Hughes RA, Swan AV and van Doorn PA:
Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane
Database Syst Rev. 9(CD0020639)2014.PubMed/NCBI View Article : Google Scholar
|
